Hepatitis B virus infection and transfusion medicine: science and the occult

O ccult hepatitis B virus (HBV) “infection” has been characterized as an obscure, covert, concealed, or hidden disease entity that is recognized in a hepatitis B surface antigen (HBsAg)-negative person whose blood and/or liver tissue is found to contain HBV DNA. While there is general consensus for this definition, uncertainty exists as to what other hepatitis B serologic criteria should be included in this description and whether hepatitis C virus (HCV) or human immunodeficiency virus (HIV) should be excluded from the equation. This has created some confusion depending on whether one is dealing with a healthy blood donor or a patient with liver disease. Additional critical issues are whether these individuals are viremic and at risk for progression of their disease or are capable of transmitting HBV to another individual. To place this in perspective, an overview of the current methods used for detecting HBV followed by a summary of the serologic patterns accompanying hepatitis B infection seems to be warranted concluding with a discussion of occult infection based on recently published articles. CURRENT MOLECULAR BIOLOGY OF HBV AND DIAGNOSTIC METHODOLOGY

[1]  J. Tanaka,et al.  Minimum infectious dose of hepatitis B virus in chimpanzees and difference in the dynamics of viremia between genotype A and genotype C , 2007, Transfusion.

[2]  W. Gerlich,et al.  Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus , 2007, Journal of viral hepatitis.

[3]  F. Hollinger Hepatitis B virus genetic diversity and its impact on diagnostic assays , 2007, Journal of viral hepatitis.

[4]  E. Vamvakas,et al.  Hepatitis B virus DNA–positive, hepatitis B surface antigen–negative blood donations intercepted by anti‐hepatitis B core antigen testing: the Canadian Blood Services experience , 2007, Transfusion.

[5]  K. Nelson,et al.  Evaluation of a multiplex human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand , 2007, Transfusion.

[6]  J. Laroche,et al.  Detection and characterization of hepatitis B virus of anti‐hepatitis B core antigen–reactive blood donors in Quebec with an in‐house nucleic acid testing assay , 2007, Transfusion.

[7]  L. Overby,et al.  Serodiagnosis of Recent Hepatitis B Infection by IgM Class Anti‐HBc , 2007, Hepatology.

[8]  T. Merigan,et al.  Antiviral Treatment of Chronic Hepatitis B Virus Infection: Infectious Virus Cannot Be Detected in Patient Serum after Permanent Responses to Treatment , 2007, Hepatology.

[9]  M. Satake,et al.  Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program , 2007, Transfusion.

[10]  K. Tadokoro,et al.  Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen–negative) infection in the acute stage , 2007, Transfusion.

[11]  J. Allain International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti‐HBc screening , 2007, Vox sanguinis.

[12]  L. Finelli,et al.  Surveillance for acute viral hepatitis--United States, 2005. , 2007, Morbidity and mortality weekly report. Surveillance summaries.

[13]  M. Raptopoulou-Gigi,et al.  Long term follow-up of a large cohort of inactive HBsAg (+)/ HBeAg (-)/ anti-HBe (+) carriers in Greece. , 2007, Journal of gastrointestinal and liver diseases : JGLD.

[14]  Z. Ullah,et al.  Anti–hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice , 2007, Transfusion.

[15]  T. Wright,et al.  Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy , 2007, Journal of viral hepatitis.

[16]  J. Koskinas,et al.  Natural History of Chronic Hepatitis B Virus Infection in Children of Different Ethnic Origins: A Cohort Study with Up to 12 Years' Follow-up in Northern Greece , 2007, Journal of pediatric gastroenterology and nutrition.

[17]  J. Allain,et al.  Characterization of HBV DNA+/HBsAg− blood donors in Poland identified by triplex NAT , 2006, Hepatology.

[18]  K. Tadokoro,et al.  Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion , 2006, Transfusion.

[19]  A. Duseja,et al.  Prolonged Hepatitis B surface antigen positivity in Hepatitis B vaccine recipients. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[20]  P. Lachenbruch,et al.  Quantification of hepatitis B virus genomes and infectivity in human serum samples , 2006, Transfusion.

[21]  J. Koskinas,et al.  Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients , 2006, Hepatology.

[22]  C. Trautwein,et al.  Report of the monothematic EASL conference on liver transplantation for viral hepatitis (Paris, France, January 12-14, 2006). , 2006, Journal of hepatology.

[23]  D. Thabut,et al.  Immune Suppression as the Etiology of Failure To Detect Anti-HBc Antibodies in Patients with Chronic Hepatitis B Virus Infection , 2006, Journal of Clinical Microbiology.

[24]  J. Tanaka,et al.  Hepatitis B virus (HBV) screening strategy to ensure the safety of blood for transfusion through a combination of immunological testing and nucleic acid amplification testing - Japanese experience. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[25]  Ding‐Shinn Chen,et al.  Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[26]  S. Kleinman,et al.  Assessing the impact of HBV NAT on window period reduction and residual risk. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[27]  W. Gerlich Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  M. Lazarini,et al.  HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors. , 2006, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[29]  B. Portmann,et al.  Reactivation of latent hepatitis B virus infection with HIV-related immunosuppression , 2006, International journal of STD & AIDS.

[30]  Fangjun Zhou,et al.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact. , 2005, International journal of epidemiology.

[31]  J. Koskinas,et al.  Natural history of chronic HBV infection: A cohort study with up to 12 years follow‐up in North Greece (part of the Interreg I‐II/EC‐project) , 2005, Journal of medical virology.

[32]  P. Holland,et al.  Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test , 2005, Transfusion.

[33]  W. Au,et al.  Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. , 2005, Journal of hepatology.

[34]  K. Nishioka,et al.  Hepatitis B NAT virus‐positive blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA , 2005 .

[35]  Tomasz P. Michalak,et al.  Persistence of isolated antibodies to woodchuck hepatitis virus core antigen is indicative of occult infection , 2004, Hepatology.

[36]  S. Glynn,et al.  Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti‐HBc: implications for future HBV screening policy , 2004, Transfusion.

[37]  C. Gibbs,et al.  Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. , 2004, Gastroenterology.

[38]  K. Kleesiek,et al.  Low‐level viraemia of hepatitis B virus in an anti‐HBc‐ and anti‐HBs‐positive blood donor , 2004, Transfusion medicine.

[39]  Joseph D. C. Yao,et al.  Multicenter Evaluation of the VERSANT Hepatitis B Virus DNA 3.0 Assay , 2004, Journal of Clinical Microbiology.

[40]  J. Allain,et al.  Occult hepatitis B virus infection: implications in transfusion , 2004, Vox sanguinis.

[41]  W. Gerlich,et al.  Transmission of Hepatitis B Virus 2 Months Prior to Hepatitis Surface Antigen Positivity of Donor Blood , 2003, Transfusion Medicine and Hemotherapy.

[42]  F. Otaǧ False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines. , 2003, Vaccine.

[43]  K. Nishioka,et al.  High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. , 2003, Journal of virological methods.

[44]  J. Molina,et al.  Reactivation of HBV replication in HIV-HBV infected patients. , 2003, The American journal of medicine.

[45]  G. Schreiber,et al.  Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection , 2003, Transfusion.

[46]  S. Glynn,et al.  Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti‐HBc: implications for transfusion transmission and donor screening , 2003, Transfusion.

[47]  H. Kiyokawa,et al.  Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening , 2003, Vox sanguinis.

[48]  S. M. Rogers,et al.  LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value , 2003, Sexually transmitted infections.

[49]  A. R. Davis,et al.  Transient hepatitis B surface antigenemia in a blood donor after a combination hepatitis A and B vaccine , 2003, Transfusion.

[50]  Ding‐Shinn Chen,et al.  Transfusion‐transmitted HBV infection in an endemic area: the necessity of more sensitive screening for HBV carriers , 2002, Transfusion.

[51]  J. Barbara,et al.  Transfusion‐transmitted hepatitis B virus infection in the UK: a small and moving target , 2002, Vox sanguinis.

[52]  H. Kirchner,et al.  Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. , 2002, Blood.

[53]  G. Galea,et al.  Hepatitis B vaccinees may be mistaken for confirmed hepatitis B surface antigen‐positive blood donors , 2002, Vox sanguinis.

[54]  B. McMahon,et al.  Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.

[55]  O. Ural,et al.  The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. , 2001, The Journal of infection.

[56]  S. Cameron,et al.  Hepatitis B virus transmission by blood donation negative for hepatitis B surface antigen, antibody to HBsAg, antibody to hepatitis B core antigen and HBV DNA , 2001, Vox sanguinis.

[57]  W. Owiredu,et al.  Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D , 2001, Journal of medical virology.

[58]  E. Sabino,et al.  Significance of isolated hepatitis B core antibody in blood donors from São Paulo. , 2001, Revista do Instituto de Medicina Tropical de Sao Paulo.

[59]  C. Bréchot,et al.  Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely “occult”? , 2001, Hepatology.

[60]  A. Prince,et al.  Infectivity of blood from PCR‐positive, HBsAg‐negative, anti‐HBs‐positive cases of resolved hepatitis B infection , 2001, Transfusion.

[61]  J. Córdoba,et al.  De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti‐HBc positivity in the donor population , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[62]  A. Heath,et al.  An international collaborative study to establish a World Health Organization international standard for hepatitis B virus DNA nucleic acid amplification techniques , 2001, Vox sanguinis.

[63]  B. McMahon,et al.  Hepatitis B virions isolated with antibodies to the pre‐S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted , 2000, Transfusion.

[64]  V. Carreño,et al.  Effects of delayed freezing of liver biopsies on the detection of hepatitis C virus RNA strands. , 2000, Journal of hepatology.

[65]  W. Jilg,et al.  High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. , 2000, The Journal of general virology.

[66]  Y. Cheng,et al.  Detection of IgM to hepatitis B core antigen in a reductant containing, chemiluminescence assay. , 1999, Journal of immunological methods.

[67]  Yuan Wang,et al.  Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen , 1999, Journal of Gastroenterology.

[68]  R. Tedder,et al.  Evidence that anti‐HBc but not HBV DNA testing may prevent some HBV transmission by transfusion , 1999, British journal of haematology.

[69]  Tomasz P. Michalak,et al.  Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. , 1999, The Journal of clinical investigation.

[70]  W. Gerlich,et al.  Quantitative Detection of Hepatitis B Virus DNA in Two International Reference Plasma Preparations , 1999, Journal of Clinical Microbiology.

[71]  P. Vereerstraeten,et al.  Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature. , 1998, Transplantation.

[72]  H. Ozen,et al.  Long-term follow-up of hepatitis B virus carriers with normal transaminases levels. , 1998, The Turkish journal of pediatrics.

[73]  K. Koike,et al.  Persistent viremia after recovery from self‐limited acute hepatitis B , 1998, Hepatology.

[74]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[75]  R. Wiesner,et al.  Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. , 1997, Gastroenterology.

[76]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[77]  F. Chisari,et al.  Long-lasting memory T cell responses following self-limited acute hepatitis B. , 1996, The Journal of clinical investigation.

[78]  M A Nowak,et al.  Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  W. Ng,et al.  Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs. , 1996, Singapore medical journal.

[80]  H. Schätzl,et al.  Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. , 1995, Journal of hepatology.

[81]  B. Grossman,et al.  Hepatitis B surface antigenemia in blood donors following vaccination , 1995, Transfusion.

[82]  L. Mimms,et al.  Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients , 1995, Transfusion.

[83]  B. Wegmüller,et al.  Reliability of PCR decontamination systems. , 1994, PCR methods and applications.

[84]  J. Fukushima,et al.  Portal hypertension in schistosomiasis: A long‐term follow‐up of a randomized trial comparing three types of surgery , 1994, Hepatology.

[85]  H. Okamoto,et al.  Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen , 1994, Journal of virology.

[86]  J. Villeneuve,et al.  A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. , 1994, Gastroenterology.

[87]  J. Wands,et al.  Properties of hepatitis B virus pre-S1 deletion mutants. , 1994, Virology.

[88]  L. Mimms,et al.  Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. , 1993, BMJ.

[89]  P. Holland,et al.  Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine , 1993, Transfusion.

[90]  A. Widell,et al.  Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg , 1993, Hepatology.

[91]  G. Meucci,et al.  The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers , 1993, Annals of Internal Medicine.

[92]  H. Okamoto,et al.  Correlation between Anti‐HBc Titers and HBV DNA in Blood Units without Detectable HBsAg , 1992, Vox sanguinis.

[93]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[94]  G. Nimmo,et al.  Isolated hepatitis B core antibody--can response to hepatitis B vaccine help elucidate the cause? , 1992, Australian and New Zealand journal of medicine.

[95]  M. Yoshiba,et al.  Post-transfusion fulminant hepatitis B after screening for hepatitis B virus core antibody , 1992, The Lancet.

[96]  N. Brown,et al.  Hepatitis B virus infection in patients with idiopathic liver disease , 1991, Hepatology.

[97]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[98]  L. Mimms,et al.  Improvements in detection of antibody to hepatitis B core antigen by treating specimens with reducing agent in an automated microparticle enzyme immunoassay , 1991, Journal of clinical microbiology.

[99]  P. Holland,et al.  Characterization of a reduction-sensitive factor from human plasma responsible for apparent false activity in competitive assays for antibody to hepatitis B core antigen , 1991, Journal of clinical microbiology.

[100]  D. Ganem,et al.  The role of envelope proteins in hepatitis B virus assembly. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[101]  R. Purcell,et al.  19S and 7-8S forms of IgM antibody to hepatitis B core antigen in acute icteric hepatitis superimposed on hepatitis B surface antigen carriage , 1990, Infection.

[102]  S. Kashiwagi,et al.  Frequency of concurrence of hepatitis B surface antigen and antibody in a large number of carriers in Okinawa, Japan , 1990, Gastroenterologia Japonica.

[103]  J. Wands,et al.  Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers , 1990, Hepatology.

[104]  G. Gerken,et al.  Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. , 1990, The New England journal of medicine.

[105]  G. Hetland,et al.  Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen‐negative hepatitis B virus carrier , 1990, Transfusion.

[106]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[107]  C. Bréchot,et al.  TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS , 1988, The Lancet.

[108]  A. Czaja,et al.  Frequency and significance of concurrent hepatitis B surface antigen and antibody in acute and chronic hepatitis B. , 1987, Gastroenterology.

[109]  M. Shapiro,et al.  Determining the size of non-A, non-B hepatitis virus by filtration. , 1987, The Journal of infectious diseases.

[110]  R. Purcell,et al.  Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. , 1987, Gastroenterology.

[111]  B. Yvonnet,et al.  Age‐ and sex‐related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal) , 1987, Journal of medical virology.

[112]  E. Schiff,et al.  A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. , 1987, The New England journal of medicine.

[113]  A. Blei,et al.  Clinical significance of concurrent hepatitis B surface antigen and antibody positivity , 1986, Digestive Diseases and Sciences.

[114]  T R Bender,et al.  Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. , 1985, The Journal of infectious diseases.

[115]  F. Gyorkey,et al.  Reduction in risk of hepatitis transmission by heat-treatment of a human Factor VIII concentrate. , 1984, The Journal of infectious diseases.

[116]  P. Hurlen,et al.  Hepatitis B serum markers and oral health in a group of Norwegian male prisoners. , 1984, Acta odontologica Scandinavica.

[117]  L. Hwang,et al.  PREVENTION OF PERINATALLY TRANSMITTED HEPATITIS B VIRUS INFECTIONS WITH HEPATITIS B IMMUNE GLOBULIN AND HEPATITIS B VACCINE , 1983, The Lancet.

[118]  S. Lemon,et al.  Low-molecular-weight IgM antibody to hepatitis B core antigen in chronic infections with hepatitis B virus. , 1983, The Journal of infectious diseases.

[119]  W. Szmuness,et al.  Incidence of hepatitis B virus infections in preschool children in Taiwan. , 1982, The Journal of infectious diseases.

[120]  P. Dubreuil,et al.  False Reactions in Radioimmunoassay for Viral Hepatitis B Markers in Patients Suffering from Coagulation Disorders , 1982, Vox sanguinis.

[121]  H. Polesky,et al.  Interpretation of various serological profiles of hepatitis B virus infection. , 1981, American journal of clinical pathology.

[122]  R. Brouwer,et al.  Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study. , 1980, Journal of virological methods.

[123]  W. Gerlich,et al.  Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. , 1980, The Journal of infectious diseases.

[124]  J. Hoofnagle,et al.  Hepatitis A and B virus markers in immune serum globulin , 1980 .

[125]  J. Melnick,et al.  Hbc ag, anti-HBC, and DNA polymerase activity in transfused recipients followed prospectively. , 1975, The American journal of the medical sciences.

[126]  J. Weiler,et al.  Risk of transfusing blood containing antibody to hepatitis-B surface antigen. , 1974, Lancet.

[127]  K. Nishioka,et al.  HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA. , 2005, Vox sanguinis.

[128]  M. Alter,et al.  Epidemiology of hepatitis B in Europe and worldwide. , 2003, Journal of hepatology.

[129]  J. Wands,et al.  Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. , 1994, Journal of hepatology.

[130]  P. Grob,et al.  Detection of HBs antigen in "anti-HBc alone" positive sera. , 1994, Journal of hepatology.

[131]  F. Chisari,et al.  Hepatitis B virus persistence after recovery from acute viral hepatitis. , 1994, The Journal of clinical investigation.

[132]  D. Ganem,et al.  Assembly of hepadnaviral virions and subviral particles. , 1991, Current topics in microbiology and immunology.

[133]  A. Lok,et al.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .

[134]  F. Tsuda,et al.  Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection. , 1984, Gastroenterology.

[135]  J. van Hattum,et al.  Co‐occurrence of HBsAg and anti‐HBs: Two consecutive infections or a sign of advanced chronic liver disease? , 1982, Journal of medical virology.

[136]  J. Allen Post-transfusion hepatitis, a serious clinical problem. , 1966, California medicine.